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ABSTRACT 
 
There is an old and famous fact “the garden is the poor man's apothecary” and treatment of each 
and every disease is hidden in nature. Medicinal plants are highly esteemed all over the world as 
a rich source of therapeutic agents for the prevention and treatment of various diseases. Since 
ages, herbs are being used for treating different ailments in different parts of world by different 
communities.  
A kidney stone, also known as a renal calculus is a solid concretion or crystal aggregation 
formed in the kidneys from dietary minerals in the urine. The problem of urinary stones or 
calculi is a very ancient one these stones are found in all parts of the urinary tract, the kidney, 
and the urinary bladder and may vary considerably in size. Urolithiasis is a complex process that 
occurs from series of several physicochemical event including super-saturation, nucleation, 
growth, aggregation and retention within the kidneys. 
Present article deals with reason, types of kidney stones, risk factors associated, diagnosis and 
treatment methods including many medicinal plants as herbal option for treatment of urinary 
stones.  
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INTRODUCTION 
Natural plant products have been used throughout human history for various purposes since more 
than 5000 Yrs and for much of history, herbal medicine was the only medicine. Herbal 
medicines are naturally occurring, plant-derived substances that are used to treat or prevent 
different diseases
1
. Medicinal plants contain complex mixtures of organic chemicals that may 
come from any raw or processed part of a plant. On an average 25 percent of the drugs 
prescribed worldwide are derived from plants
2
. Of the 252 drugs in the World Health 
Organization’s essential medicine list, 11 percent are exclusively of plant origin3.  
Herbal medicine, also called botanical medicine, uses the plant’s seeds, berries, roots, leaves, 
bark or flowers for medicinal purposes. At present scenario, many researchers are working on 
different medicinal plants to create the pharmaceutical products
4
.  
Urolithiasis (nephrolithiasis) or kidney stones is the condition characterized by formation of 
urinary calculi in the urinary tract. It is a common disorder affecting approximately 12% of the 
population, with a recurrence rate of 70-81% in males, and 47-60% in females. Urine contains  
chemicals that prevent the crystals from forming
5
. However these inhibitors do not seem to work 
for everyone, thus stones are developed in some people form. If the crystals remain tiny enough,  
they will travel through the urinary tract and pass out of the body in the urine without being 
noticed. Urinary stones of up to 5 mm. of diameter are generally passes through the urinary tract, 
whereas those exceeding 7 mm
6
. of diameter almost always require surgical intervention. It 
causes serious health problems such as severe pain at the end of urination, urinary-tract 
obstruction and infection that adversely affect well-being of individuals
7
.  
In general, urolithiasis affects all age groups from less than 1 year old to more than 70 yrs. The 
risk of stones formation is generally high in men 2–4 times, which could be due to the larger 
 muscle mass of men as compared to women, enhancing capacity of testosterone and inhibiting 
capacity of oestrogen in stones formation. Moreover male urinary tract being more complicated 
than the female urinary tract . Estrogen may also help to prevent the formation of calcium stones 
by keeping urine alkaline and raising protective citrate levels
8
.  
Calculi can occur in various sites in the urinary tract in the following order of frequency i.e. 
vesical < renal < ureteral < urethral. In general, the occurrence of calculus is higher in the lower 
part of the urinary tract in all age groups
9
. 
Many synthetic drugs like diuretics and narcotic analgesics are used in treatment of kidney 
stones. However overuse of these drugs, results in higher incidence of adverse drug reactions. 
Shock wave lithotripsy, ureteroscopy, percutaneous  nephrostolithotomy, and open or 
laproscopic stones removal are the treatment approaches for kidney stones
10
. However these 
treatment methods are costly and painful are non-convenient for patients.  There are many 
medicinal plants that have shown to be effective in treatment of kidney stones disease. In the 
present article, an attempt has been made to emphasize on potent medicinal plants that are used 
in treatment of urolithiasis
11
. 
TYPES OF STONES  
There are several types of renal stones having composition and pathogenesis. The stones types 
are named after its mineral composition. These chemicals are part of a person’s normal diet and 
make up important parts of the body, such as bones and muscles. 
1. Calcium stones  
Most kidney stones are calcium stones, combined with oxalate, phosphate, or occasionally uric 
acid. Calcium oxalate crystal formation is also one of the toxic effects of ethylene glycol 
poisoning. Oxalate is a naturally occurring substance found in food. Some fruits, vegetables, nuts 
and chocolate, have high oxalate levels. Liver also produces oxalate. Dietary factors, high doses 
of vitamin D, intestinal bypass surgery and several metabolic disorders can increase the 
concentration of calcium or oxalate in urine. All calcium stones are radio-opaque, and calcium 
oxalate and calcium phosphate stones are black, grey, or white and small (1cm in diameter)  
dense and sharply circumscribed on radiographs. Calcium oxalate stones appear as 'envelopes' 
microscopically. The formation of calcium phosphate stones is associated with conditions such 
as hyperparathyroidism and renal tubular acidosis
12
. 
2. Uric acid stones  
Uric acid stones are smooth, round, yellow-orange and nearly radiographically transparent. 
About 5–10% of all stones are formed from uric acid. Uric acid stones can form in people who 
don't drink enough fluids or who lose too much fluid, those who eat a high-protein diet, diets 
high in purines, especially those containing meats and fish and those who have gout certain 
metabolic abnormalities; including obesity  or certain genetic factors also may increase your risk 
of uric acid stones
18
. These patients also have a tendency to form urate stones. Urate stones are 
especially common after colon resection. Uric acid stones appear as pleomorphic crystals, 
usually diamond-shaped, squares or rods which are polarizable
13
.  
3. Struvite or infection or triple phosphate stones  
Struvite is a crystalline substance composed of magnesium ammonium phosphate. About 10–
15% of urinary calculi are composed of struvite. Struvite stones form most often in the presence 
of infection by urea-splitting bacteria. Using the enzyme urease, these organisms metabolize urea 
into ammonia and carbon dioxide. This alkalinizes the urine, resulting in favorable conditions for 
the formation of struvite stones. They are also commonly seen in people with underlying 
metabolic disorders, such as idiopathic hypercalciuria, hyperparathyroidism, and gout.  
 Struvite stones are large, gnarled, and laminated. These stones can grow quickly and become 
quite large, sometimes with few symptoms or little warning. Signs of struvite stones include 
urinary pH greater than 7, staghorn calculi, and urease that grow bacteria on culture (proteus, 
klebsiella, pseudomonas)
14
. 
4. Protease-related stones  
This is the newest type of stones. The increasing incidence of HIV-positive patients has led to 
widespread use of the protease inhibitor indinavir sulphate. In 4–12% of patients this drug, may 
leads to formation of stones
15
. 
5. Cystine stones.  
These stones are rare and form in people with a hereditary disorder that causes the kidneys to 
excrete too much of certain amino acids (cystinuria). People who are homozygous for cystinuria 
excrete more than 600 mg per day of insoluble cystine. The stones are greenish- yellow,flecked 
with shiny crystallites, and are moderately radio-opaque with a rounded appearance
16
. 
6. Silicate stones or drug induced stones  
These are stones are found very rarely. These stones can form as a result of taking certain 
medications or herbal products like loop diuretics, acetazolamide, topiramate, zonisamide, 
laxatives (when abused), ciprofloxacin, sulfa medications, triamterene, indinavir, ephedrine, 
guaifenesin, and products containing silica
17
. 
Table 1: Different types of stones 
S.N. Stone types Constituents % Incidence of 
all stones 
1.  Calcium oxalate  Calcium, oxalate  70 %  
2.  Calcium phosphate  Calcium, phosphate  10 %  
3.  Uric acid  Uric acid  5-10 %  
4.  Struvite  Calcium, ammonia, phosphate  10 %  
5.  Cystine  Cystine  Less than 1%  
6.  Medication-
induced stones  
Composition depends on medication or herbal 
product (examples include indinavir, 
ephedrine, guaifenesin, silica)  
Less than 1%  
 
CAUSES OF UROLITHIASIS  
Kidney stones often have no definite, single cause, although several factors may be responsible 
for it. Kidney stones form when urine contains more crystal-forming substances such as calcium, 
oxalate and uric acid than the fluid in urine gets diluted. At the same time, urine may lack 
substances that prevent crystals from sticking together, creating an ideal environment for kidney 
stones to form. Dietary factors that increase the risk of stones formation include low fluid intake 
and high dietary intake of animal protein, sodium, refined sugars, calcium oxalate, grapefruit 
juice, apple juice, fructose and high fructose corn syrup, and cola drinks
18
.  
Other reason for stones formation includes inadequate urinary drainage, foreign bodies in urinary 
tract, microbial infections, vitamin abnormalities like vitamin A deficiencies, excess vitamin D, 
and metabolic diseases like hyperthyroidism, cystinuria, gout, intestinal dysfunction etc
19
.  
In order to form stones within the urinary tract, urine must be supersaturated for precipitating 
crystalline component. The agents which can modify nucleation, crystallization, and aggregation, 
pH of the urine also play important role in stones formation. Some reports have described that 
vegetarians are at lower risk for stones formation in contrast to non-vegetarians
20
. 
 A family history of kidney stones (increases risk by three times), insulin resistant states, a history 
of hypertension, primary hyperparathyroidism, a history of gout, chronic metabolic acidosis, and 
surgical menopause are all associated with increased risk of kidney stones. 
Various drug that increase the risk of stones disease i.e. decongestants (ephedrine, guaifenesine),  
diuretics (triamterene),  protease inhibitors (indinavir),  anticonvulsants (felbamate, topiramate). 
Pathogenesis of kidney stones based on two basic aspects
21
- 
1.  Increased urinary excretion of stones forming constituents like calcium, phosphorus,  
uric acid, oxalate and cysteine.  
2. Physicochemical changes that influence stones formation like pH of urine, stones matrix and  
protective substances in urine. 
Symptoms of kidney stones include colicky pain, nausea/ vomiting, hematuria, pyuria, dysuria, 
oliguria.  
Table 2: Stone promoters and inhibitors 
 
Stone 
promoters 
Low urine volume, calcium, low urine 
pH, sodium oxalate, urate 
Stone 
Inhibitors 
Inorganic inhibitors, citrate, 
magnesium, osteopontin 
glycosaminoglycans, organic 
inhibitors, prothombin fragment 
 
Mechannism of calcium oxalate stone formation 
Exact mechanism of stone formation is not clearly understood. The proposed mechanism 
includes following steps 
1. Urinary supersaturation- 
Urine is a highly saturated solution containing various crystalloids and colloids. Urine does not 
precipitate under normal condition due to presence of stone forming inhibitors present in urine. 
When the urine becomes supersaturated (when the urine solvent contains more solutes than it can 
hold in solution) with one or more calculogenic (crystal-forming) substances, a seed crystal may 
form through the process of nucleation
22
. 
2. Formation of nidus (crystal nucleation) 
The first step in the transformation from a liquid to a solid phase in a supersaturated solution is 
termed as nucleation. This process starts with the combination of stone salts in solution into 
loose clusters that may increase in size by addition of new components or clusters. Nuclei form 
the first crystals that do not dissolve and have a characteristic lattice pattern. In urine, nuclei 
usually form on existing surfaces, a process called heterogeneous nucleation. Epithelial cells, 
urinary casts, RBCs, and other crystals can act as nucleating centers in urine.  
3. Crystal Growth 
Whenever a crystal nucleus achieved a critical size and relative supersaturation remains above 
one, the overall free energy is decreased by adding new crystal components to the nucleus. This 
process is called crystal growth. Crystal growth is one of the prerequisites for particle formation 
and thus for stone formation. In each step of stone formation, crystal growth and aggregation 
have important functions
23
.  
4. Crystal Aggregation 
In this process crystals in solution stick together to form larger particles. It is the most important 
step in stone formation. Although crystal growth is definitely a step in renal stone formation, the 
process of growth is so slow that crystals cannot become large enough to obstruct the renal 
 tubules and be retained there by this mechanism alone, as several minutes are required for the 
tubular fluid to pass through the kidney. Crystal aggregation is promoted by viscous binding, 
implying that crystal-foreign compounds with multiple binding sites, such as abnormally self-
aggregating Tamm-Horsfall glycoprotein or other macromolecules, attach to crystal surfaces and 
act as a kind of glue
24
. 
5.  Crystal-Cell Interaction 
Crystal-cell interaction mechanism is very complex, and many of them remain unexplored. 
Crystallization is caused by the condition of urinary supersaturation. Then, the crystals that have 
formed attach to renal tubular epithelial cells and are taken into them.  
DIAGNOSIS OF UROLITHIASIS  
Diagnosis  of urolithiasis is done on the basis of clinical symptoms of the location and severity of 
the pain. Imaging like x-ray, computed tomography, ultrasound is used to confirm the presence 
of stones
22
. 
Furthermore, a number of other tests can be undertaken to help establish both the possible cause 
and consequences of the stones. Microscopic study of urine, to detect presence of proteins, red 
blood cells, bacteria, cellular casts and crystals.  Blood tests for the presence of a raised white 
cell count (neutrophilia) suggestive of infection, a check of renal function and to look for 
abnormally high blood calcium blood levels (hypercalcaemia). 
TREATMENT AND PREVENTION OF UROLITHIASIS  
Prevention and treatment of recurrent urolithiasis aims to increase the daily fluid intake to at 
least 2.5 L to 3 L per day along with pain controlling drugs and medications to monitor salts that 
may increase or reduce formation of stones. In general physicians usually do not treat kidney 
stones, they just medicate the pain until the stones pass out their own
23
. Vegetarian diet, to drink 
plenty of water, heavy on herbs, can be helpful in the prevention and treatment of kidney stones. 
The severe nature of renal colic has promoted a lower threshold at which narcotic analgesic, 
thiazide like diuretic and potassium citrate is prescribed. The available drugs used to prevent 
urolithiasis are not effective in all patients, and many of them are associated with adverse effects 
that compromise their long term use
24
.  
However, most of these standard pharmaceutical drugs used to prevent and cure urolithiasis are 
not effective in all cases, costly, quite common reoccurrences, risks of long term fertility, 
potential side effects and no guarantee. 
For treatment of urolithiasis medicinal or surgical procedure is carried out. Surgical treatment 
like- 
1. Shock wave treatment which is the only non-invasive treatment for stones disease 
2.  Endoscopic management, both ureterenooscopic and percutaneous nephrolithotomy provides 
an efficient way to treat stones. 
ROLE OF MEDICINAL PLANTS AS ANTIUROLITHIATIC AGENTS- 
One of the best way to prevent and treat urolithiasis is to control the process of crystallization 
events. This is best achieved by the use of herbal extracts since they have been widely used in 
folk medicine to treat kidney stones. Herbal remedies, are regarded as quite safe with minimal or 
no side effects, cost effective, readily available and easily affordable. 
Following are the drugs that are used for treatment of kidney stones. Listed selected plants as 
like in table are used for kidney diseases mostly, diuresis, renal stones and cleansing the kidneys. 
 
 
 
 
 Table 3: List of medicinal plants used in urolithiasis and urinary tract trouble 
Plant Family Part used 
Abutilon indicum (L.)
25
  Malvaceae  
Seed and 
Leaf 
extract 
Amaranthus spinosus(L.)
26
  Amaranthaceae  Root or plant  
Argemone maxicana(L.)
18
  Papaveraceae  Root  
Amaranthus viridis(L.) 
11 
Amaranthaceae  All parts  
Abrus precatorius Linn.
17
  Malvaceae  Leaves  
Abutilon indicum Linn.
27
  Malvaceae  Whole plant  
Actinodaphne angustifolia (Blume) 
Nees
28 Lauraceae  Leaves 
Aeschynomene indica Linn
29
  Papilionaceae 
Young 
tender leaves 
Aerava lanta(L.)
30
  Amaranthaceae  Leaves  
Ageratum conyzoides(L.)
22
  Asteraceae  Leaves  
Amaranthus caudatus(L.)
24
  Amaranthaceae  Leaves  
Bambusa nutans Wall.
28
  Poaceae  Shoots 
Bauhinia acuminata 
Linn.
25 Caesalpiniaceae  
Bark or 
leaves 
Bonnaya brachiata Link
31
 
and Otto.  
Scrophulariaceae  Whole plant  
Bonnaya reptans (Roxb.)
32
 
Spreng.  
Scrophalariaceae  Whole plant 
Benincasa hispida (Thund.) Cogn
33 
Cucurbitaceae Fruit 
Berberis aristata DC
34
  Berberidaceae  Leaves 
Beta vulgaris(L.)
35
  Amaranthaceae  Rhizomes  
Bombex ceiba (L.)
36
  Bombacaceae  
Stem and 
bark  
Borhaavia difffusa (L.)
37
  Nyctagenaceae  Root  
Cordia grandis Roxb.  Boragineae  Fruits  
Costus speciosus (Koening) Smith
38
.  Zingiberaceae  Roots  
Crinum asiaticum Linn
39
  Amaryllidaceae  Bulb  
Curcuma angustifolia Roxb
40
  Cucurbitaceae  Whole plant  
Chenopodium album(L.)
27
  Chenopodiaceae  Leaves  
Coculus hirsutus(L.)
37
  
Menispeermacea 
e 
Leaves  
Corbichonia decumbens
41
 
(Forrsk.) 
Molluginacae  Leaves  
Capsella bursa pastoris (Linn.) Medik
42
  Brassicaceae  Whole plant  
Cardamine hirsuta Linn
43
  Brassicaceae  
Whole plant 
except root  
Cassia fistula(L.)
26
  Caesalpinioideae  Fruit  
Celosia arigentia
29
  Amaranthaceae  Seed  
Ceropegia bulbos(L.)
44
  Asclepidaceace  Tubers  
 Carica papaya Linn. 
33 
Caricaceae  Young Fruit  
Celosia argentea Linn.
37
  Amaranthaceae  Roots  
Celtis timorensis Span
45 
Ulmaceae  Aerial parts 
Centella asiatica (Linn.) 
Urban.
40
  
Apiaceae  Whole plant  
Cinnamomum bejolghota 
(Buch.-Ham.) Sweet.
25
  
Lauraceae  Bark  
Daucas carota(L.)
46
  Apiaceae  -  
Digera Muricata(L.)
28
  Amaranthaceae  Leaves  
Diospyros melaoxylon(Rox)
47
  Ebenaceae  
Fruit and 
bark  
Equisetum debile (Roxb.)
48
  Equisetaceae  All parts  
Gomphrena celosioides20(Mart.)
49
  Amaranthaceae  Whole plant  
Grewia flavescens (A.Juss)
50
  Tiliaceae  Root  
Pedalium murea (L.)
51 
Pedaliaceae  Fruits  
Phy1llanthus emblica(L.)
35
  Euphorbiaceae  Seed Powder  
Phyllanthus fraternus  (Webster.)
52
  Euphorbiaceae  Whole plant  
Pedalium murea(L.)
48
  Pedaliaceae  Fruits  
Solanum nigrum Linn
53
  Solanaceae  Seeds 
Stephania hernandifolia 
Walf.
28 Menispermaceae  Leaves 
Syzygium aromaticum 
(Linn.) Merr. and Perry.
35 Myrtaceae  Flower bud 
Solanum surattence  Solanaceae  Root powder  
Tinospora cordifolia(Wild.L)
29
  Menispermaceae  Stem  
Tribulus terrestis(L.)
54
  Zygophyllaceae  Leaves  
Tridex procumbens(L.)
55
  Asteraceae  Leaves  
Tubiflora Acaulis(L.F.)
56
  Acanthaceae  Leaves  
Tagetes erecta Linn.
57
  Asteraceae  Leaves 
Tamarindus indica Linn
58
  Caesalpinaceae  Leaves 
Thunbergia alata Boj. 
Ex Sims.
59 Acanthaceae  Leaves 
Wedelia chinensis (Osb.)
58
 
Merril.  
Asteraceae  Whole plant 
Xanthium strumarium 
Linn.
60
 
Asteraceae  Roots 
  
CONCLUSION 
Since ancient times, medicinal plants has wide acceptance due to a large no. of advantages such 
as lesser toxic effects, safe, effective, cheap, less chances of recurrence of disease, easily 
available in rural areas. There is no proper medicine in allopathy for the treatment of urolithiasis, 
and those drugs are present are having side effects. Furthermore the surgical treatment is another 
option but it has the more chances of recurrence. So, medicinal plants are considered suitable for 
the treatment of kidney stones.  
 The present review containing information of kidney stones and plants used as antiurolithiasis 
agents, it will help in guiding the researcher to identify new source of drugs for this ever 
prevailing human ailment to overcome the various disadvantages faced by the wide range of 
population now-a-days and get relieve from the disease.  
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